WallStreetZenWallStreetZen

NASDAQ: ENSC
Ensysce Biosciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Be the first to know when Wall Street analysts revise their ENSC stock forecasts and price targets.

Forecast return on equity

Is ENSC forecast to generate an efficient return?
Company
N/A
Industry
-71.71%
Market
19.68%

Forecast return on assets

Is ENSC forecast to generate an efficient return on assets?
Company
N/A
Industry
7.14%

ENSC revenue forecast

What is ENSC's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$1.7M
Avg 2 year Forecast
$13.6M
Avg 3 year Forecast
$39.6M

ENSC vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
ENSC$0.56N/AN/A
BDRX$0.81$8.00+890.10%Strong Buy
SCPX$0.16N/AN/A
TCON$1.85$60.00+3,143.24%Buy
SNGX$0.40N/AN/A
View Top Biotech Stocks

Ensysce Biosciences Stock Forecast FAQ

What is ENSC's revenue growth forecast for 2024-2026?

(NASDAQ: ENSC) Ensysce Biosciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 59.36%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.3%.

Ensysce Biosciences's revenue in 2024 is $0.On average, 2 Wall Street analysts forecast ENSC's revenue for 2024 to be $12,093,134, with the lowest ENSC revenue forecast at $8,795,006, and the highest ENSC revenue forecast at $15,391,261. On average, 2 Wall Street analysts forecast ENSC's revenue for 2025 to be $99,728,043, with the lowest ENSC revenue forecast at $16,124,178, and the highest ENSC revenue forecast at $183,331,908.

In 2026, ENSC is forecast to generate $290,235,211 in revenue, with the lowest revenue forecast at $290,235,211 and the highest revenue forecast at $290,235,211.

If you're new to stock investing, here's how to buy Ensysce Biosciences stock.

What is ENSC's forecast return on assets (ROA) for 2024-2026?

(NASDAQ: ENSC) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 7.14%.

What is ENSC's forecast return on equity (ROE) for 2024-2026?

(NASDAQ: ENSC) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.